TIVC SCHEDULE 13D/A: Insider sale planned

Filed with the SEC on · accession 0001753926-26-001610

TIVC filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 24, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

3i, LP sold shares of Valion Bio, Inc. common stock over August 20-24, 2026, including 443,361 shares sold in open-market transactions and 2,020,404 shares acquired upon conversion of Series C Preferred Stock.

Key details

Open-market sale of common stock on 08-20-2026$403K
Open-market sale of common stock on 08-21-2026$18K
Open-market sale of common stock on 08-24-2026$22K
Shares acquired upon conversion of Series C Preferred Stock on 08-20-2026$2.0M
Reporting person / selling shareholder3i, LP
IssuerValion Bio, Inc.

✦ Ask GOAX AI about this filing — what it means for TIVC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TIVC?

Click here

Frequently asked questions

What did TIVC file with the SEC on Aug 24, 2026?

TIVC filed a SCHEDULE 13D/A (Insider sale planned). 3i, LP sold shares of Valion Bio, Inc. common stock over August 20-24, 2026, including 443,361 shares sold in open-market transactions and 2,020,404 shares acquired upon conversion of Series C Preferred Stock.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

Other TIVC SEC filings

Get alerts when TIVC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days